COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • April 30th, 2015 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Notwithstanding the foregoing, in case the daily drug price of the Product determined by Regulatory Authority is lower than […***…], then the Milestone Payment of $[…***…] on […***…] is to be a credit against the royalties payable to Neurocrine pursuant to the Section 8.3.
